RxDoctor Payments Data

Jennifer Ladd, DO

Family Medicine · Charleston, WVNPI 1275732216

Payments from drug & device makers

$6,755in general payments, 2019–2025

Across 385 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1K
  • Novo Nordisk$1K
  • AbbVie$579
  • Novartis$559
  • GSK$413
  • Sanofi-aventis U.S. LLC$345
  • plus $3K from 39 others

What the payments were for

  • Food & beverage$6,739100%
  • Education$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,755 in reported general payments places this provider in the 90th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$43,515
Medicare patients
155
Services billed
709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide96$147,842
JanuviaSitagliptin Phosphate81$96,583
EliquisApixaban70$89,869
MounjaroTirzepatide48$85,196
RybelsusSemaglutide45$63,908
JardianceEmpagliflozin39$55,635
FarxigaDapagliflozin Propanediol41$46,787
LinzessLinaclotide46$44,518
XareltoRivaroxaban45$44,517
TrulicityDulaglutide35$41,681
Tresiba Flextouch U-200Insulin Degludec53$35,509
Spiriva HandihalerTiotropium Bromide24$29,193
EntrestoSacubitril/Valsartan18$22,055
TradjentaLinagliptin21$21,148
SymbicortBudesonide/Formoterol Fumarate47$17,247

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,086$211,750141 claims
Lilly USA, LLCMounjaro, Trulicity$285$126,87683 claims
MerckJanuvia$161$96,58381 claims
PfizerEliquis, Premarin$1,149$96,20583 claims
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$157$88,91076 claims
AstraZenecaFarxiga, Symbicort$323$64,03388 claims
AbbVieLinzess, Synthroid$579$48,80696 claims
GSKBreo Ellipta, Trelegy Ellipta, Incruse Ellipta$413$45,28067 claims
Johnson & JohnsonXarelto$49$44,51745 claims
NovartisEntresto$559$22,05518 claims
Astellas Pharma US IncMyrbetriq$90$12,61418 claims
Sanofi-aventis U.S. LLCLantus$345$3,50415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Charleston

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →